IFNB1 and myocarditis: IFN-β administration in patients with enteroviral or parvovirus-B19-induced myocarditis in clinical studies showed to be safe and have ameliorating effects, so interferon treatment in myocardium SARS-CoV-2 myocarditis may be promising [110,111,112].